How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...

Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet. The Intellis system is designed to treat chronic pain by ...

Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, ...

The three University of Colorado campuses, including CU Boulder, announced a partnership on Thursday with the global ...

Medtronic plc (NYSE:MDT) is one of the top stock picks in Ken Griffin’s portfolio. On August 25, analysts at TD Cowen reiterated a ‘Buy’ rating on the stock and a $106 price target. The bullish stance ...

Medtronic posted $4.19 billion in fourth-quarter U.S. revenue and $29.95 billion in fiscal year 2018 revenue. Here are six notes. 1. Medtronic reported fourth quarter 2018 worldwide revenue of $8.14 ...

Interdisciplinary multimodal pain treatments yield small but clinically relevant improvements in pain and physical functioning for patients with chronic pain.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on ...